Pharmacia execs
This article was originally published in The Tan Sheet
Executive Summary
CEO Fred Hassan advises Pfizer he will not join firm's Board of Directors as vice chairman, Pfizer announces April 14. With Federal Trade Commission approval of merger of Pharmacia with Pfizer occurring the same day, Hassan says he plans to "pursue other career opportunities" later this month. Hassan is said to be a front runner for the CEO post at Schering-Plough (1"The Tan Sheet" April 7, 2003, p. 10). Separately, Pharmacia R&D President Goran Ando will leave the company to serve as CEO for UK biotech firm Celltech...
You may also be interested in...
Schering CEO Selection Being Closely Watched By Investors
Schering-Plough's appointment of a new CEO, following the retirement of Richard Kogan later this month, could steady the firm's share price and help it weather what is expected to be a difficult year
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.